InvestorsHub Logo
Followers 97
Posts 128742
Boards Moderated 1
Alias Born 07/24/2016

Re: None

Thursday, 02/23/2017 11:39:05 AM

Thursday, February 23, 2017 11:39:05 AM

Post# of 16597

$IMLFF InMed Pharmaceuticals Inc. is a pre-clinical stage biopharmaceutical company specializing in the research, development and commercialization of cannabinoid-based therapies to treat human diseases with high unmet medical needs. The Company has three core assets: a proprietary Bioinformatics assessment tool to match individual (or combination of) cannabinoids against disease targets, a proprietary Biosynthesis cannabinoid manufacturing system to economically produce all 90+ cannabinoids at pharmaceutical-grade (>99.5% purity), and drug development program.

The full research report has a comprehensive overview of InMed's financials, pipeline and potential obstacles READ MORE

(Copy and paste to your browser may be required to view the full report- http://bit.ly/2kA730w-IMLFF-Analyst)

https://finance.yahoo.com/news/inmeds-cannabis-pipeline-financials-prospects-130000009.html

$VBIO $GWPH $AXIM

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.